Introduction {#S1}
============

Uropathogenic *Escherichia coli* (UPEC) is the most ubiquitous pathogen implicated in urinary tract infections (UTIs), accounting for 80--90% of all infections ([@B1], [@B2]). Numerous studies have reported the prevalence of various virulence factors among UPEC isolated from the urinary tract including the adhesins (Type 1, P, S, and F1C fimbriae), toxins (RTX and CNF-1), pore-forming hemolysin, aerobactin, and multiple sideophore-based iron acquisition systems ([@B3]--[@B7]). Several publications report the existence of these virulence factors in clusters, small virulence cassettes, or large blocks of genes in enteropathogenic, enterohaemorragic, and UPEC strains, not observed in the genome of fecal isolates ([@B3], [@B8]--[@B14]). These factors are often linked or co-regulated, acting in concert according to host response and environmental signals ([@B15]). Such features contribute to the adherence, colonization, multiplicity, propagation, and persistence of UPEC strains within the mammalian host's urinary tract, despite hydrodynamic challenges encountered ([@B16]).

The adhesion of UPEC to mucosal cells is the most vital step for the initiation of UTI and is mediated by P and Type 1 fimbriae, binding to digalactoside-containing globoseries glycosphingolipids and mono [d]{.smallcaps}-mannose residues, respectively ([@B17]--[@B21]). However, this report focuses on the vastly studied, mannose-resistant *pap* (pyelonephritis-associated pili) fimbriae by which genotypic studies have identified the gene in approximately 80% of *E. coli* isolates that cause pyelonephritis ([@B15]). The *pap* operon mainly consists of fimbriae structural subunits (*pap*A, -C, -D, -E, -F, -G); subunit to terminate fimbrial growth and anchor mature fimbriae to host cell surface, *pap*H; and the divergently encoded regulatory genes *pap*B and *pap*I, within which the main promoter is located. Expression of these promoters is dependent on the methylation status of the two GATC sites within the intergenic region ([@B19], [@B22]). Although there are reports that support fimbriae-mediated UPEC adherence *in vitro* ([@B7], [@B23], [@B24]), the significance of P fimbriae for infectivity has not been confirmed as only subtle adherence roles were exhibited in uroepithelial cell culture models ([@B25]).

DNA methylation is a vital epigenetic, postreplicative alteration that is catalyzed by a class of enzymes referred to as the DNA methyltransferases (MTases). Crucial to the regulation of many cellular processes in eukaryotes and prokaryotes, DNA adenine methylase (Dam) plays numerous roles in DNA mismatch repair, transcriptional regulation, and SOS response stimulation as part of the cell cycle ([@B26]--[@B30]). In *E. coli*, the *Dam* enzyme catalyzes the postreplicative transfer of methyl from *S*-adenosyl-[l]{.smallcaps}-methionine to the N-6 position of adenine in the tetranucleotide GATC sequence in hemimethylated DNA ([@B28], [@B31]--[@B34]). Conserved for the manifestation of virulent genes, *Dam*'s essential function in pathogenesis has also been reported in several bacterial species including *E. coli, Salmonella enterica* serovar Typhimurium, *Yersinia* spp*., Haemophilus influenzae, Vibrio cholera*, and *Pasterella multocidas* ([@B28], [@B31], [@B32], [@B35]). The presence of GATC sites in the −10 and −35 hexamers of promotor regions, directly affecting gene expression by regulating the binding of transcriptional factors or RNA polymerase according to methylation state at the sites, serves to substantiate this phenomenon.

Though not essential to the viability of *E. coli*, Dam's involvement in transcriptional modulation was first proven through detailed studies of *pap* operon encoding pili necessary for UTI in UPEC ([@B26], [@B28], [@B31], [@B33], [@B35]--[@B40]). The *pap* pili-mediating adhesion of UPEC to mammalian uroepithelial cells is epigenetically regulated through methylation at the intergenic region of *pap*IB to produce "ON/OFF" phase variation (expression or non-expression, respectively) by individual cells ([@B30], [@B34], [@B38], [@B41]). The phase variation mechanism *via* Dam methylation pattern acts a switch for the expression of the operon and confirms reports for the significance of Lrp, PapI, and Dam as transcription regulators ([@B28], [@B31], [@B34], [@B38], [@B42], [@B43]). The reversible expression of *pap* is theorized to allow the bacteria to attach and detach from the urogenital tissues, which in turn enables colonization and infection ([@B33]).

Previous research indicates Dam-deficient (Dam^−^) mutants of pathogenic *Salmonella* serovar Typhimurium being rendered avirulent with the overexpression of over 35 genes ([@B44]) and downregulation of others, preferentially expressed during infection. This was made evident by Badie et al. ([@B36]) signifying amplified defects in the gene expression of virulence genes for flagellin synthesis, motility, and bile resistance in pathogenic *Salmonella* strain 14028 ([@B34]). To date, studies centered on the modulation of responses in the host immune system to attenuated *Salmonella* Dam-serovars have indicated that greater immunity is conferred to vaccinated hosts ([@B36]) and may be highly effective as live vaccines against murine typhoid fever in an increased attenuated state ([@B33], [@B45]) taking in consideration the persistence of Dam mutants in infected animals ([@B46]).

In contrast, Dam^−^ mutants of *E. coli* have demonstrated increased expression for numerous genes including s*ul*A, *trp*S, *trp*R, *tyr*R, and *gln*S, within which GATC sites are localized within the −10 and −35 region of their promoters ([@B34], [@B47]). Likewise, the increased adherence and actin pedestal formation on cultured mammalian cell lines for Δ*dam* mutants of Enterohemorrhagic *E. coli* (EHEC) OH157:O7 when compared to wild type strains speaks to the epigenetic effect of *dam* on various bacterial species ([@B26]). Within this milieu, this study was conducted to determine the epigenetic influence of *dam* on growth, fluoroquinolone resistance, gene expression, and human uroepithelial cell attachment in UPEC by the employment of lambda (λ) red recombineering.

Materials and Methods {#S2}
=====================

Bacterial Strains, Growth Conditions, and Culture Medium {#S2-1}
--------------------------------------------------------

A total of 174 non-duplicate uropathogenic fluoroquinolone-resistant *E. coli* strains isolated from patients diagnosed with uncomplicated UTI were analyzed prior to epigenetic studies ([@B48], [@B49]). Uropathogenic control strain *E. coli* CFT073 \[genotype *amp*^R−^, *dam*^+^, MDR^−^, *qnr*A^−^, QRDR^−^, *pap*EF^+^\] ([@B50]) and fluoroquinolone-resistant *qnr*A^−^, and cured quinolone-resistance determining region (QRDR)-positive *E. coli* clinical isolates A620b, C119, U155 \[genotype *amp*^R−^, *dam*^+^, MDR^+^, *qnr*A^−^, QRDR^+^, *pap*EF^+^\] ([@B48]) were utilized for epigenetic studies. Fluoroquinolone-resistant *qnr*-positive control strains *E. coli* strain Lo QnrA^+^ and *E. coli* J53 pMG252 were generously donated by Dr. G. A. Jacoby and Prof. P. Nordmann, respectively. *E. coli* ATCC 25922 and MG1655, non-pathogenic negative controls used were generously provided by the Microbiology Department at the University Hospital of the West Indies (UHWI), Mona, Jamaica and the University of Minnesota, respectively. Multidrug-susceptible uropathogenic *E. coli* CFT073 \[WAM2267\] and J53 Az^R^ served as control strains in antibiotic susceptibility and Dam methylation studies (ATCC, VA, USA). In addition, the laboratory *E. coli* strain MG1655 and JM109 \[genotype K-12sp *rec*A^−^, *end*A^−^, F′\] (Promega, WI, USA) were utilized as *dam-*positive control and competency for cloning, respectively. All isolates were routinely cultured in either Luria-Bertani (LB) medium (Difco™, BD Diagnostics, MD, USA) or Tryptic Soy agar (EMD Millipore, Merck, Darmstadt, Germany) supplemented with antibiotics including ampicillin (100 μg/ml), carbenicillin (125 μg/ml), chloramphenicol (10 or 15 μg/ml), ciprofloxacin (1 μg/ml), and nalidixic acid (40 μg/ml) (Cellgro^®^, Mediatech Inc., VA, USA or Sigma-Aldrich, MO, USA), where appropriate. When performing genetic transformations, the Super Optimal Broth (SOB) medium (AMRESCO, OH, USA) served as a nutrient-rich medium for the resuscitation of cells. All strains were incubated at 37°C unless indicated otherwise.

Plasmids {#S2-2}
--------

Plasmids utilized were: (a) temperature-sensitive helper plasmid pKM208 (8731 bp) that harbors λ red genes including *bet, gam* and *exo* and *amp*^R^ gene under the control of P~tac~ promoter and *lacI* repressor ([@B51]); (b) pKD3 (2804 bp) (Genbank AY048742) to obtain the chloramphenicol acetyl transferase gene template required for linear DNA preparation for recombineering experiments ([@B52]); (c) cloning plasmid pGEM^®^-T Easy Vector (3015 bp) that encodes the *amp*^R^ gene (Promega, WI, USA) or pCR^®^II-TOPO (4.0 kb) and *amp*^R^ + *kan*^R^ conferring ampicillin and kanamycin resistance (Invitrogen, CA, USA), respectively.

DNA Manipulations {#S2-3}
-----------------

### *Dam* Screening {#S2-3-1}

Prior to determining the putative influence of the *dam* gene on the P fimbriae attachment and quinolone resistance among fluoroquinolone-susceptible and -resistant UPEC, strains were subjected to screening for *dam*. UPEC isolates were subjected to genomic DNA extraction using the Promega Wizard Genomic DNA Extraction kit (Promega, WI, USA) according to the manufacturer's instructions. DNA extracts were quantified using the Thermoscientific Nanodrop 2000 Spectrophotometer (Wilmington, DE, USA) followed by *dam* amplification by PCR using Promega GoTaq Green 2× kit (Promega, WI, USA), 1 μl DNA and the UR427/UR428 primer pair (Table [1](#T1){ref-type="table"}) to produce an amplicon size of 1071 bp. Forward primer UR427 was located upstream the *dam* gene while UR428 was located further downstream. As a foundation for primer design, *E. coli* laboratory strain K-12 substrain MG1655 ([@B53]) was used to augment the 837 bp *dam* gene and flanking regions. PCR reactions were performed using the GeneAmp 9700 Thermal Cycler (Applied Biosystems, USA) according to the following parameters: 95°C for 5 min (initial denaturation), 29 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 1 min, and 72°C for 10 min (final extension). Amplicons were detected by UV fluorescence following electrophoresis in ethidium bromide-stained agarose gels.

###### 

**Primers, sequence, and amplicons size used in epigenetic influence of Dam studies**.

  Gene/region                          Primer                                                                  Sequence (5′-3′)                                                       Band Size (bp)   Reference
  ------------------------------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------- ---------------- ------------
  Dam                                  UR427                                                                   CTAG[TCTAGA]{.ul}TGTACGCTTCGAAAGAAGAGG                                 1071             This study
  UR428                                CCCG[CTCGAG]{.ul}ATCAGCCGACAGAATTGAGG                                                                                                                           
  *dam* deletion (*cam*^R^ cassette)   UR429C                                                                  CACAGCCGGAGAAGGTGTAATTAGTTAGTCAGCATGAAGAAAAATCGCGTGTAGGCTGGAGCTGCTTC   1323             This study
  UR430C                               TTTCATCCGCTTCTCCTTGAGAATTATTTTTTCGCGGGTGAAACGACTCCCATATGAATATCCTCCTTA                                                                                           
  QRDR (Topoisomerase II)              GyrA6                                                                   CGACCTTGCGAGAGAAAT                                                     626              ([@B54])
  gyrA631                              GTTCCATCAGCCCTTCAA                                                                                                                                              
  QRDR (Toposiomerase IV)              ParCF43                                                                 AGCGCCTTGCGTACATGAAT                                                   849              ([@B55])
  ParCF981                             GTGGTAGCGAAGAGGTGGTT                                                                                                                                            
  *dam* (*E. coli* CFT073)             damCFT073-F                                                             ACTTCCATGGGACAGAATTGAGGGGGCA                                           996              This study
  damCFT073-R                          AAGCGTCGACATCAAGGTTATCTCCCGCAA                                                                                                                                  
  *qnr*A gene (pMG252)                 damqnrA-F                                                               TCTTAGTCGACAAGATCCGAAGGTCATTGAGC                                       1236             This study
  damqnrA-R                            TCGGCCATGGATGAAGCAACCAGGCAATG                                                                                                                                   
  Insert coding sequence               M13-F                                                                   CGCCAGGGTTTTCCCAGTCACGAC                                                                
  M13-R                                TCACACAGGAAACAGCTATGAC                                                                                                                                          
  *pap* promoter region                papIB--F                                                                TTTCTGAACAGGCATGATGG                                                   418              This study
  papIB-R                              GTGAGCGCTGAACCATACCT                                                                                                                                            
  P fimbriae assembly                  papEF-F                                                                 GCAACAGCAACGCTGGTTGCATCAT                                              336              ([@B56])
  papEF-R                              AGAGAGAGCCACTCTTATACGGACA                                                                                                                                       

*UR427 -- XbaI restriction enzyme site*.

*UR428 -- XhoI restriction enzyme site*.

### DNA Methylation Assay {#S2-3-2}

Chromosomal and plasmid DNA from *dam*-positive *E. coli* isolates A620b, cured C119 (cC119), U155, uropathogenic *E. coli* CFT073 and *dam*-positive control strain *E. coli* MG1655 were subjected to differential digestion for *dam* function with restriction endonucleases *Sau*3AI, *Mbo*I, and *Dpn*I according to Chen et al. ([@B61]) with modifications. Essentially, 0.5 μg of chromosomal and plasmid DNA was digested for 1.5 h at 37°C with 2 U *Sau*3AI (Promega, WI, USA), 10 U *Dpn*I (New England Biolabs, MA, USA), or 2.5 U *Mbo*I. *Sau*3AI cleaves DNA at GATC sites regardless of methylation state, *Dpn*I cleaves GATC sites that have a methylated adenine residue, and *Mbo*I cleaves unmethylated GATC sites. The resulting DNA was visualized under UV on ethidium bromide-stained agarose gels.

### Dam Mutant Construction {#S2-3-3}

*dam* deletion mutants were created *via* the λ red recombinase system involving a modified one-step allelic exchange and inactivation protocol as proposed by Datsenko and Wanner ([@B52]) and illustrated in Figure [1](#F1){ref-type="fig"}A. Clinical and control UPEC strains containing the Red recombinase helper plasmid pKM208 were generated following electroporation using the BIORAD Gene Pulser X-cell Electroporation System (2 kV, 25 μFD, and 200 Ω). After recovery of cells in SOC medium (Invitrogen, CA, USA) at 37°C for 1 h, 100 μl of the electroporation mixture was plated in triplicate on LB agar with 125 μg/ml carbenicillin and incubated overnight with agitation at 30°C to maintain the replication of the temperature-sensitive pKM208 within the cells.

![**Genotypic and growth characteristics displayed by parental and *dam-*mutant strains of UPEC**. **(A)** Schematic diagram of gene disruption strategy for chromosomal insertion of chloramphenicol resistance gene from pKD3 into *dam* gene within UPEC chromosome subsequent to λ red recombineering with pKM208. **(B)** Amplified *dam* fragment from wild type UPEC strains CFT073 (lane 1) and cured parental strains C119 (lane 2) to produce 1071 bp amplicon. MW is 1 kb DNA ladder (Bioneer Corporation, Republic of Korea) and −ve is negative control. **(C)** PCR screening of UPEC candidates for *dam* mutation observed as 1323 bp products using primers UR427 and UR428. MW is a 1 kb Plus DNA ladder (Invitrogen, USA). **(D)** Dam methylation pattern in UPEC CFT073 wild type (lanes 1, 2, 8, 9, 14, 15), C119 wild type (lanes 3, 4, 10, 11, 16, 17), and *E. coli* K-12 substrain MG1655 (5, 12, 18) strains subsequent to digestion with *Mbo*I, *Sau*3AI, and *Dpn*I. The negative control (7, 13, 19) and 1 kb Plus DNA ladder (MW) are also shown. **(E)** Dam methylation pattern in UPEC *dam* mutants CFT073 (lanes 1, 2, 3, 8, 9, 10, 15, 16, 17) and C119 wild-type (lanes 4, 5, 6, 11, 12, 13, 18, 19) subsequent to digestion with *Sau*3AI, *Mbo*I, and *Dpn*I. The negative control (lanes 7, 14) and 1 kb Plus DNA ladder (MW) are also shown. **(F)** Growth curve (CFU/milliliter versus time) for UPEC strains CFT073, CFT073 Δ*dam*, cC119, and cC119 Δ*dam*.](fpubh-04-00131-g001){#F1}

To construct the DNA fragment to be used for allelic exchange to make the *dam* deletion mutation, PCR amplification of the chloramphenicol cassette (*cam*^R^) was conducted using the pKD3 template ([@B52]) and the *dam* insertion primer pair UR429C/UR430C. Each primer carried extra sequence overhangs of 50 bp genome homology to either the 5′ end (UR429C) or 3′ end (UR430C) of the *dam* gene, followed by approximately 20 bp sequence homology to the chloramphenicol resistance gene (*cam*^R^) to generate an amplicon that inserted the resistance gene roughly 50 bp into the coding sequence of the *dam* gene (Δ*dam*:*cam*^R^ fragment). PCR parameters included initial denaturation at 95°C for 5 min, 29 cycles of 95°C for 30 s, 55°C for 30 s and 72°C for 1 min 30 s, and final extension at 72°C for 10 min. Following electrophoresis, the 1113 bp band was purified by gel extraction by the QIAquick Gel Extraction kit (QIAGEN Sciences Inc., MD, USA) according to the manufacturer's instructions in a final volume of 50 μl water and quantitated as previously described.

Electrocompetent suspensions of IPTG-induced (1 mM) *E. coli* strains A620b, cC119, U155, and CFT073 (all harboring pKM208) were electroporated with 5 μl of purified Δ*dam*:*cam*^R^ PCR product and recovered in SOC medium. Recombinant clones were selected on LB agar supplemented with 10 μg/ml chloramphenicol and incubated at 37°C. To facilitate the loss of pKM208 from carbenicillin-resistant transformants, previously screened transformants were plated on medium with 10 μg/ml chloramphenicol and incubated at 42°C overnight. Recombinant clones were verified by plating on medium containing the appropriate antibiotic for incubation at 37°C. Selected strains were chloramphenicol resistant and carbenicillin sensitive. Presumptive colonies were further confirmed for the presence of the Δ*dam*:*cam*^R^ allele (1323 bp) by PCR using primers UR427/UR428 as previously described prior to *dam* methylation assays and observations under the light microscope (WARDS Natural Science Establishment, Inc., NY, USA).

### Complementation of *Dam* and *dam*qnrA {#S2-3-4}

Complementation vectors pGEM*dam* or pGEMQA were constructed by inserting the *dam* and *qnr*A genes amplified from *E. coli* CFT073 and C119 wild-type, respectively, into Promega pGEM^®^-T Easy vector system (Promega, WI, USA) according to the manufacturer's recommendations. PCR amplification was conducted individually using the corresponding laboratory-designed primer pairs damCFT073-F/damCFT073-R and damqnrA-F/damqnrA-R (Table [1](#T1){ref-type="table"}) under parameters suitable for selected sequence. The DNA band of interest was excised and gel purified (IBI Scientific, KappCourt, IA, USA) followed by cloning in pGEMdam or pGEMQA according to the Promega pGEM^®^-T Easy vector system. Subsequently, presumptive colonies were screened by PCR, subjected to genomic and plasmid DNA extraction and quantification as previously described. Complement strains were further tested for *dam* function by the Dam methylation assay and visualized under the light microscope (WARDS Natural Science Establishment, Inc., NY, USA).

Growth Rate Studies {#S2-4}
-------------------

To investigate the impact of *dam* on UPEC growth rate, wild-type (CFT073), cured parental (C119), Δ*dam* and complement Δ*dam* strains of *E. coli* CFT073 and C119 were grown to saturation in LB with appropriate antibiotics at 37°C, the growth rate measured by UV/Vis spectrophotometer (Cecil CE 9000 series, Cecil Instruments Limited, Cambridge, UK) and viable cell count method according to a modified protocol by Matlock et al. ([@B62]). A 2% batch culture was prepared by transferring 2 ml of an overnight culture in 100 ml. The culture was grown for up to 10 h, during which the optical density at 600 nm and associated viable cell count (CFU/milliliter) was determined following duplicate plating on LB agar incubated overnight at 37°C. Results were obtained from three separate experiments. Growth rate (*k*) was calculated as: $$k = \frac{\log 10\left\lbrack X_{t} \right\rbrack - \log 10\lbrack X_{0}\rbrack}{0.301 \times t} = {gen/h}$$ where *X*~t~ is the higher CFU/milliliter, *X*~0~ is the lower CFU/milliliter, and *t* is the time interval between both (in hours).

Generation time (*t*~gen~) was calculated as: $$\text{t}_{\text{(gen)}} = \text{1/}k = \text{h/gen}$$

Antimicrobial Susceptibility {#S2-5}
----------------------------

Wild-type and Δ*dam-*mutant strains of *E. coli* CFT073 and cured C119 as well as control strains *E. coli* strain Lo QnrA^+^ and *E. coli* JM109 harboring pGEMQA were subjected to antimicrobial susceptibility testing using Sensititre Substrate-in-Well GNUR2F Gram-negative MIC plates (TREK Diagnostic Systems, Inc., OH, USA) for inoculation and incubation ([@B63]). A 50 μl suspension of the sample was used to inoculate Sensititre plates, sealed and incubated at 35°C for 18--24 h. The plates were observed for the presence of a growth button at the base of the microtiter well and fluorescence intensity (+++ to 0) captured with a UV Benchtop Variable Transilluminator and Photo Doc-It Imaging System (UVP, CA, USA).

Biofilm Analysis {#S2-6}
----------------

The correlation of *dam* with oxygen and antiobiotic pressure on the formation of biofilms in the presence and absence of 2% [d]{.smallcaps}-mannose (AMRESCO, OH, USA) were explored. First, overnight cultures of bacterial strains were diluted 1:10 into Mueller-Hinton broth, 0.2 ml transferred into 96-well polystyrene microtiter plates (Nunc-Immuno Microwell) and incubated at 37°C for 24 h without agitation. Oxidative stress studies were initiated by the addition of hydrogen peroxide (H~2~O~2~) to microwell cultures to a final concentration of 0, 0.1, 0.2, 0.3, 1, or 2 mM, prior to incubation and processing as indicated by a modification to concentrations utilized by Hedge et al. ([@B64]) and Hryckowian et al. ([@B65]). Likewise, for the effect of the antimicrobial agents, the quinolones, nalidixic acid (0, 8, 24, 32, 40, or 48 μg/ml), and ciprofloxacin (0, 1, 2, 3, 4, or 5 μg/ml) were added to microwell cultures prior to incubation. Post 24 h incubation, wells were decanted, washed thrice with 1× phosphate-buffered saline (PBS, pH 7.4), and adhered bacterial cells stained with 200 μl 0.1% crystal violet for 15 min at room temperature. Unbound dye was decanted, wells washed thrice, and dried. Stained cells were dissolved with 95% ethanol for 15 min, and optical density measured at 570 nm using Victor X Multilabel Plate Reader (PerkinElmer, MA, USA). All experiments were conducted in triplicate from three independent experiments ([@B20]). Statistical data analysis was conducted using the Student's *t* test for variance in data collected from test strains when compared to parental or wild type (SPSS software, Version 20, SPSS Inc., USA). A *p* value of \<0.05 was considered statistically significant.

Transcriptional Analysis {#S2-7}
------------------------

In order to determine the impact of *dam* on DNA transcription, cured parental, *dam* mutant and complement strains of C119 and CFT073 were cultured overnight then subjected to RNA isolation and purification using the Promega SV RNA Isolation Kit (Promega, WI, USA) according to the manufacturer's instructions. Reverse Transcription was conducted using the GoScript™ Reverse Transcriptase System First-Strand Synthesis System (Promega, WI, USA) to synthesize first-strand cDNA as instructed by the manufacturer. cDNA was amplified by means of semi-quantitative PCR (sq-PCR) for *dam, pap*IB, *pap*EF, *qnr*A, and the housekeeping genes (*arc*A, *gyr*B, *mdh, rec*A, and *rpo*S) expression in *E. coli* C119 and CFT073 parental, mutant, and complement strains using GoTaq^®^ Green Reaction Mix and gene-specific primers (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}), annealed at 55°C for 1 min. Ten microliter samples were taken at cycles 23, 25, 30, and electrophoresed in ethidium bromide-stained agarose gels ([@B66]).

###### 

**Primers, sequence, and amplicons size used in epigenetic influence of Dam studies (continued)**.

  Gene/region                           Primer                                Sequence (5′--3′)                  Amplicon size (bp)   Reference
  ------------------------------------- ------------------------------------- ---------------------------------- -------------------- -----------
  Aerobic respiration control protein   arcA-F                                GAAGACGAGTTGGTAACACG               645                  ([@B57])
  arcA-R                                CTTCCAGATCACCGCAGAAGC                                                                         
  DNA gyrase subunit B                  gyrB-F                                TCGGCGACACGGATGACGGC               911                  ([@B58])
  gyrB-R                                ATCAGGCCTTCACGCGCATC                                                                          
  Malate dehydrogenase                  mdh-F                                 ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG   932                  ([@B58])
  mdh-R                                 TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT                                                           
  ATP/GTP-binding motif                 recA-F                                CGCATTCGCTTTACCCTGACC              780                  ([@B58])
  recA-R                                TCGTCGAAATCTACGGACCGGA                                                                        
  Transcription factor sigma S          rpoS-F                                TATGAGTCAGAATACGCTGAAA             Varies               ([@B59])
  rpoS-R                                GGAACAGCGCTTCGATATTCAG                                                                        
  Quinolone-resistance gene             qnrA-F                                ATTTCTCACGCCAGGATTTG               516                  ([@B60])
  qnrA-R                                GATCGGCAAAGGTTAGGTCA                                                                          

Phenotypic Influence of *Dam* Methylation on P Fimbriae {#S2-8}
-------------------------------------------------------

The *pap*I-B pili regulatory region was identified using the *pap*IP1for/*pap*IP1rev primers as described by Holden et al. ([@B67]). The concentrated, purified 418-bp PCR product of the *pap*I-B regulatory region from strains U155 and C119 (\~1.8 ng in 3.5 μl) was cloned into Invitrogen pCRII^®^ TOPO vector (Invitrogen, CA, USA) according the manufacturer's instructions to construct pSAMS1 and pSAMS2, respectively, further used to transform One Shot *E. coli* competent cells (Invitrogen, CA, USA). Transformants were selected on LB supplemented with 50 μg/ml carbenicillin/40 mg/ml X-gal/100 mM IPTG, prior to recombinant vector purification by QIAprep Spin Miniprep kit (QIAGEN Inc., CA, USA). The cloned *pap* intergenic DNA insert was confirmed by colony PCR with M13F/M13R primers, sequenced at the Virginia Commonwealth University Core Facility in Richmond, VA, USA and analyzed using NCBI BLAST. *dam* methylation of the *pap*I--*pap*B insert was determined as previously described in the [Materials and Methods](#S2){ref-type="sec"} prior to pSAMS digestion by *Eco*RI (Promega, WI, USA) to release the intergenic region.

*pap*I Expression Assay {#S2-9}
-----------------------

In order to determine variation in *pap*I expression, wild-type and *dam-*mutant strains of cC119 and CFT073 were cultured overnight then subjected to RNA isolation and RT-PCR using the QIAGEN RNeasy Mini kit, Invitrogen Superscript™ First-Strand Synthesis System (Invitrogen, CA, USA), respectively according to the manufacturer's instructions. cDNA templates were amplified by means of semi-quantitative PCR using *pap*ICFT073-1F/*pap*ICFT073-1R primers (Table [1](#T1){ref-type="table"}) as described by Holden et al. ([@B67]). Ten microliter aliquots were processed as previously noted.

Attachment Assays {#S2-10}
-----------------

Urinary human cell lines, HEK-293 (human embryonic kidney cells) and HTB-9 (human bladder cells) (ATCC, VA, USA) were individually cultured in 25-cm^2^ flasks prior to washing attached cells with 10 ml Dulbecco's phosphate-buffered saline (D-PBS) before trypsin (ATCC) exposure. Cells were incubated for 10 min at room temperature until the monolayer was almost detached, followed by the addition of 9 ml minimal essential media (MEM) with 10% fetal calf serum (ATCC) and amino acids (Cellgro^®^), and RPMI-1640 media with glucose, HEPES and 10% fetal calf serum for HEK-293 cells and HTB-9 cells, respectively. Cells and suitable medium (1:1) were added in duplicates to six-well cell culture plates following 1:4 areal dilution and incubated at 37°C in 5% CO~2~ for 48 h until confluent. One set of cell culture plates was utilized for assessment of total *E. coli* cells present, and the other for assessment of adherent *E. coli* cells only. Simultaneously, *E. coli* control, cured parental, and *dam-*mutant strains of C119 and CFT073 were cultured in LB without shaking for 48 h. Prior to the attachment assay, MEM (HEK-293 cells) and RPMI-1640 (HTB-9 cells) were aspirated from the wells and 1 ml of the appropriate medium supplemented with 20% (1.1M) [d]{.smallcaps}-mannose (Sigma-Aldrich) added to each well. Furthermore, 10 μl bacterial culture (OD = 1 at 600 nm) mixed with 1.8 μl of 20% [d]{.smallcaps}-mannose was added to each well. Samples were evenly distributed, centrifuged for 5 min at 600 × *g*, and incubated at 37°C in 5% CO~2~ for 1.5 h. At the end of incubation, plates designated for the detection of adherent *E. coli* cells were washed five times with Dulbecco's PBS with 1 mM CaCl~2~ and 0.5 mM MgCl~2~ (PBS^2+^), 40 μl Triton X-100 added to lyse the cells, and the bottom of wells scraped. Sterile PBS^2+^ was added to the wells and mixed before serially diluting to 10^4^ (100 μl sample to 900 μl PBS^2+^) for plating on LB agar. In contrast, plates selected for the determination of total number of bacteria were not subjected to washing but direct treatment with Triton-X, scraping, serial dilution and plating on LB agar. All plates were incubated overnight at 37°C, and CFU/milliliter determined and analyzed.

Results {#S3}
=======

Dam Methylation Pattern, Growth Rate and Phenotypic Characteristics of UPEC *Dam* Mutants {#S3-1}
-----------------------------------------------------------------------------------------

Of the 174 FQ-R resistant isolates including cured UPEC strains A620b, C119, U155, CFT073, and MG1655 screened, 71% were positive for the *dam* sequence amplified by UR427/UR428 to produce a 1071 bp product (Figure [1](#F1){ref-type="fig"}B). Chromosomal digestion of parental UPEC strains cC119 and CFT073 with methylation-sensitive enzymes (*Dpn*I and *Mbo*I) revealed the presence of functional *dam* capable of GATC methylation within wild-type strains (Figure [1](#F1){ref-type="fig"}D). To assess the putative role of *dam* on virulence, *dam*-deficient mutant strains were successfully constructed using Red-recombinase-mediated allelic exchange as the wild-type *dam* gene was interrupted with a chloramphenicol-resistance (*cam*^R^) gene (Figure [1](#F1){ref-type="fig"}A). Two UPEC strains (C119 and CFT073) were successfully transformed with pKM208. Successful replacement of the wildtype *dam* gene was selected for by growth of chloramphenicol-resistant Δ*dam* colonies and PCR amplification of a 1323 bp product due to the Δ*dam*:*cam*^R^ allele (Figure [1](#F1){ref-type="fig"}C). Further confirmation was revealed by a total loss of DNA adenine methylation and methylase-sensitive digestion among *dam* mutants (Figure [1](#F1){ref-type="fig"}E).

Microscopic observations revealed phenotypic variation in the population of *dam-*mutant strains: elongated bacilli or interconnected filamentous cells contributed up to 60% of the total population when compared to the shortened rods exclusively exhibited by wild-type strains (Figure [2](#F2){ref-type="fig"}C). Given that average length of wild type *E. coli* cells can vary between 1.6 and 3.9 ± 0.9 μm according to growth phase and condition ([@B68]), cell measurements were largely excluded. Despite this, filamentous cells demonstrated an estimated increase in cell length by up to eight times that of wild-type strains.

![**Genetic and growth characteristics displayed by *dam-*complemented mutant strains of UPEC relative to wild-type**. **(A)** Dam methylation pattern in UPEC CFT073 strain subsequent to digestion with *Dpn*I (lane 1) and *Mbo*I (lane 2). The 1 kb plus DNA ladder (MW) is also shown. **(B)** Growth curve (CFU/milliliter versus time) for *dam* complement UPEC strains of CFT073, CFT073 Δ*dam*, cC119, and cC119 Δ*dam*. **(C)** Micrographs for wild-type (WT) and *dam* mutant (Δ*dam*) UPEC strains, illustrating the morphological occurrence of shortened- and filamentous rods, respectively. **(D)** Semi-quantitative RT-PCR for *mdh, rec*A, and *arc*A expression at cycles 23, 25, and 30 for CFT073 (lanes 1--3), CFT073 Δ*dam* (lanes 4--6), CFT073 + pGEMdam (lanes 7--9), CFT073 Δ*dam* + pGEMdam (lanes 10--12). The 100 bp molecular marker MW (Promega, WI, USA) and negative control are shown (lane 13).](fpubh-04-00131-g002){#F2}

Complementation of *Dam* Mutants {#S3-2}
--------------------------------

To successfully construct the complementation plasmid pGEM*dam* or *qnr*A-containing pGEMQA, the corresponding *dam* (996 bp) or *qnr*A (1236 bp) amplicon from wild-type strains were used as inserts for cloning into the vector pGEM-T^®^ Easy. Furthermore, plasmids were also successfully transformed into study strains (cC119 and CFT073) for further analysis. Micrographs and *dam* function analysis in *dam* complement strains reflected the successful morphological and phenotypic restoration of *dam* denoted by the predominance of shortened rods and regular *dam* methylation (Figure [2](#F2){ref-type="fig"}A) as displayed by paternal strains.

Growth Rate Studies {#S3-3}
-------------------

Despite exhibiting comparable spectrophotometric growth trends to cured parental strains, Δ*dam* mutants exhibited at least twofold reduction in actual growth rate, cell numbers, and an extended lag phase (90--180 min) before initiating logarithmic growth in broth cultures (Figure [1](#F1){ref-type="fig"}F). There were distinguishable differences in colony forming unit per milliliter over time among all four strains titred to determine viable cell counts. Δ*dam* mutants were significantly lower (\~4.5- to 50-fold) in numbers when compared to wild-type counterparts at the end of log phase. Generation time (*t*~gen~) derivations were 13.5 min/gen (CFT073 wt), 32.3 min/gen (CFT073 Δ*dam*), 28.2 min/gen (cC119), and 55.32 min/gen (cC119 Δ*dam*); an approximate 50% reduction in growth rate of *dam-*mutant strains.

On the other hand, the restoration of the *dam* function by complementation for cured parental and Δ*dam* strains, resulted in discernable decreases in viable count over time when compared to strains lacking the plasmid (Figure [2](#F2){ref-type="fig"}B). *dam* complement strains produced marginally higher values than wild types harboring the *dam* plasmid; the lag phase of plasmid-bearing wild types being as high as 330 min. Furthermore, respective generation time derivations of 28.8, 35.4, 56.4, and 26.4 min/gen for CFT073 + pGEM*dam*, CFT073 Δ*dam* + pGEM*dam*, cC119 + pGEM*dam*, and cC119 Δ*dam* + pGEM*dam* illustrated the role of the *dam* plasmid in suppressing cell division defects linked to Dam.

Antimicrobial Susceptibility of pGEMQA-Positive Δ*dam* Mutants and Wild Type Strains {#S3-4}
------------------------------------------------------------------------------------

Susceptibility responses to various antimicrobial agents varied among wild type, Δ*dam*- and pGEMQA-harboring stains (Table [3](#T3){ref-type="table"}). A decrease in resistance by eightfold was noted for cC119 versus cC119 Δ*dam* against amoxicillin/clavulanic acid, trimethoprim/sulfamethoxazole and gentamicin, and fourfold against ciprofloxacin. For CFT073 Δ*dam*, a 32-fold (each) and 64-fold increase in resistance was identified against amoxicillin/clavulanic acid, ampicillin, and carbenicillin, respectively. In contrast, the resistance response of *dam* mutant *qnr*A complement cC119 strain was similar to the parental strain, with the restoration of resistance by eightfold (trimethoprim sulfamethoxazole and gentamicin) and fourfold (amoxicillin/clavulanic acid and ampicillin). Likewise, *dam*-mutant *qnr*A complement CFT073 maintained the susceptibility pattern identified among Δ*dam* strains.

###### 

**Antimicrobial susceptibility responses of *E. coli* wild type (wt), cured (c), *dam* mutant, and pGEMQA-bearing strains subjected to the sensititre substrate-in-well GNUR2F Gram-negative MIC plate test**.

  Strain                  MIC (μg/ml)                                           
  ----------------------- ------------- ------- --- ---- --- ---- --- --------- ---
  CFT073 wt               0             0       0   0    0   0    0   0         0
  CFT073 Δ*dam*           32            32/16   0   64   0   0    0   0         0
  CFT073 wt + pGEMQA      32            32/16   0   64   0   0    0   0         0
  CFT073Δdam + pGEMQA     32            32/16   0   64   0   0    0   0.5/9.5   0
  cC119                   32            32/16   0   64   4   32   8   4/76      0
  cC119 Δ*dam*            8             8/4     0   32   1   0    0   0.5/9.5   0
  cC119 wt + pGEMQA       32            32/16   0   64   4   4    0   4/76      0
  cC119 Δ*dam* + pGEMQA   32            32/16   0   64   2   0    8   4/76      0
  Lo QnrA^+^              32            8/4     0   64   1   0    8   4/76      0
  JM109 pGEMQA            32            16/8    0   64   0   0    0   4/76      0

*AMP, ampicillin; AUG2 -- amoxicillin/clavulanic acid; AXO, ceftriaxone; CAR, carbenicillin; CIP, ciprofloxacin; FEP, cefepime; GEN, gentamicin; SXT, trimethoprim/sulfamethoxazole; NIT, nirofurantoin*.

Transcriptional Analysis {#S3-5}
------------------------

The twofold increased expressions of *rec*A and *pap*IB were noted among Δ*dam* strains compared to cured strains of C119 and CFT073 (Figure [2](#F2){ref-type="fig"}D). Remarkably, results indicated up to threefold increase in expression among Δ*dam* strains bearing pGEMQA. With the restoration of *dam* through pGEM*dam*, Δ*dam* strains reverted to the original level of expression demonstrated by wild types. Parental strains harboring pGEMdam did not display alterations in *rec*A expression. However, Δ*dam* strains harboring pGEMQA displayed elevated *qnr*A levels (twofold) relative to cured parental strain, while those with pSAMS presented up to five times elevation in *pap*IB expression relative to parental strains. The impact of *dam* deficiency on the expression of *arc*A and *mdh* was revealed by reduced expression among *dam* mutants by 0.5-fold except for strain CFT073 (3× lowered *arc*A expression). *pap*EF expression was singly identified in CFT073 + pGEMQA strains at extremely low levels. Equally, *dam-*mutant strains did not express *dam*. However, *dam* restoration was observed though 0.5 times lower in intensity relative to parental strains.

Biofilm Analysis {#S3-6}
----------------

The impact of oxidative stress and quinolone presence on the formation of biofilms formed by cured parental and *dam-*mutant strains (with or without complementation plasmid) was examined to simulate cell aggregation intensity during infections. Overall, our findings point to greater levels of biofilm formation based on *A*~570~ values among plasmid-free *dam* mutants than wild-type strains in the absence of environmental stress. (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). Box and whisker plots for biofilm formation in the presence of peroxide stress revealed the discernible positive impact of *dam* mutation on UPEC biofilm formation in all concentrations tested. Interestingly, all phenotypes except wild-type strains harboring pGEMdam attained elevated values at 1 mM with *dam* complemented strains, exhibiting median values analogous to both mutant and cured wild type. Exposure to increasing concentrations of peroxide resulted in elevated levels of biofilm formation (up to 1 mM for CFT073 strains), followed by a 20% gradual decrease among cC119 strains (Figures [3](#F3){ref-type="fig"}A,B). OD readings were notably higher for plasmid-free Δ*dam* strains when compared to cured parental strains despite lower biofilm percentages. This was denoted by the general decrease up to 40 mM notwithstanding CFT073 mutant strains' increase in biofilm formation (*p* \< 0.001). Furthermore, cell aggregation detection among CFT073 was 30% greater than cC119 strains. Dam-complemented strains of CFT073 were also shown to revert to comparable and appreciably stable levels of surface adherence as the wild-type, with increasing peroxide concentration.

![**Distribution analysis of biofilm formation for wild type (WT), Δ*dam*, WT + pGEMdam, and Δ*dam* + pGEMdam UPEC strains of CFT073 (A) and cC119 (B) in various hydrogen peroxide (H~2~O~2~) concentrations**.](fpubh-04-00131-g003){#F3}

In contrast, exposure to quinolones-favored biofilm-forming capabilities of mutant strains as median values increased from 0 to 8 μg/ml NAL (Figures [4](#F4){ref-type="fig"}A,B). Correspondingly to oxidative stress studies, wild type strains (particularly those carrying pGEMdam) exhibited poor biofilm formation as values obtained were more skewed than mutant strains. Remarkably, the pronounced effects of plasmid pGEMQA on cured parental and *dam-*mutant strains were apparent since increased levels of biofilm formation were obtained despite increasing quinolone concentration.

![**Distribution analysis of biofilm formation for wild type (WT), Δ*dam*, WT + pGEMdam, Δ*dam* + pGEMdam, pGEMQA-harboring UPEC strains of CFT073 (A) and cC119 (B) in various peroxide and nalidixic acid (NAL) concentrations**.](fpubh-04-00131-g004){#F4}

The biofilm formation ability of plasmid-free parental strain C119 served as the baseline for quinolone pressure comparisons to Δ*dam* strains and statistical analysis, except where CFT073 harbored pGEMQA, since wild type phenotypes of the strain are susceptible to antimicrobial agents. Supplementation with nalidixic acid resulted in an overall inhibition, and decrease in biofilm formation as NAL concentration increased (Figures [4](#F4){ref-type="fig"}A,B). Notwithstanding this inhibition, proliferation among *dam-*mutant strains was marginally higher in contrast to wild type, notably among CFT073 mutant strains carrying pGEMQA (twofold increase at 8 μg/ml NAL). Furthermore, NAL resistance and biofilm formation in cC119 *dam-*mutant strains harboring pGEMQA (*p* \< 0.05) were restored to levels similar to the plasmid-free NAL-resistant parental strains. Studies with second generation quinolone, ciprofloxacin, were limited to cC119 for reasons indicated beforehand. Similar outcomes including the initial proliferation of plasmid-free cC119 Δ*dam* strain at 0 μg/ml (*p* \< 0.05) were observed. However, steady decreases up to 5 μg/ml CIP were noted, notwithstanding proliferation at 1 μg/ml. Marginally higher levels of biofilm formation were observed among Δ*dam* strains, steadily decreasing with an increase in CIP concentrations. Notably, mutant cells harboring pGEMQA exhibited fluctuations in response in comparison to steady levels of cell aggregation displayed by parental and Δ*dam* strains harboring pGEMdam.

Role of *Dam* in *pap*I-B Methylation {#S3-7}
-------------------------------------

*pap*I's role in the regulation of the P fimbriae epigenetic switch also led explorations on whether *pap*I-B regions were methylated and if there were discrepancies in *pap*I expression for *dam*-deficient and *dam*-positive cells from UPEC clinical isolates. To begin examining these questions, the initial detection of P fimbriae *via pap*EF (336 bp) screening was coupled to *pap*I-*pap*B (418 bp) detection (Figures [5](#F5){ref-type="fig"}A,B) and cloning into pCR^®^II-TOPO10^®^ to successfully produce recombinant plasmids pSAMS1 (cU115) and pSAMS2 (cC119) (Figure [5](#F5){ref-type="fig"}C). For further testing on the interaction of *dam* and *pap*I-B, UPEC Δ*dam* strains and non-pathogenic control strain *E. coli* JM109 were successfully transformed with pSAMS, the *pap*I--*pap*B insert excised by *Eco*RI and subjected to a *Dam* methylation assay to reveal methylation (Figure [5](#F5){ref-type="fig"}D). Moreover, semi-quantitative RT-PCR used to deduce the potential influence of *dam* on the expression of *pap*-associated genes and compare *pap*I expression in cured parental and *dam* mutant UPEC strains reflected an approximate twofold increase in the transcription level of the *pap*I gene in Δ*dam* strains (Figure [5](#F5){ref-type="fig"}E).

![**Phenotypic influence of Dam on P fimbriae**. **(A)** PCR screening for *pap*EF in UPEC strains cC119 (lane 4), CFT073 (lane 5), and cU155 (lane 6). The 100-bp molecular weight marker (Invitrogen), negative control and positive control (*E. coli* strain Lo *qnr*A^+^/*pap*EF^+^) are represented as MW, 1 and 2, respectively. **(B)** PCR screening for *pap*I--*pap*B intergenic regulatory region in UPEC strains from UPEC strains cC119 (lane 2), CFT073 (lane 3), and cU155 (lane 4). The 1-kb plus molecular marker (Invitrogen, CA, USA), negative control, and positive control (*E. coli* strain Lo *qnr*A^+^/*pap*EF^+^) are represented as MW, 2 and 5, respectively. **(C)** Schematic representation of pSAMS1 recombinant plasmid containing cloned *pap*IB insert within pCRII--TOPOII vector. **(D)** Dam methylation patterns for *pap*I-B regulatory region. *Sau*3AI (lane 2), *Mbo*I (lane 3), and *Dpn*I (lane 4) digests of pSAMS2 isolated from cC119 are shown. MW represents the 1 kb Plus molecular marker (Invitrogen). An undigested *pap*IB fragment (lane 5) is also represented. **(E)** Semi-quantitative (sq) RT-PCR for *pap*I expression in cC119 (lane 1), cC119 Δ*dam* (lane 2), CFT073 wild-type (lane 3) and CFT073 Δ*dam* (lane 4). The 1 kb Plus molecular marker (Invitrogen) and amplified chromosomal DNA for UPEC strains cC119 and CFT073 are shown in lanes MW, 5 and 6, respectively.](fpubh-04-00131-g005){#F5}

Effect of *Dam* on UPEC's Attachment to Mammalian Cells {#S3-8}
-------------------------------------------------------

To examine the effect of Dam on UPEC's interaction with mammalian cells, the ability of *dam*-deficient versus *dam*-proficient UPEC cells to adhere to cultured uroepithelial cells *in vitro* was examined. Δ*dam* strains demonstrated threefold (CFT073) to fourfold higher (cC119) cell binding levels to HEK-298 cells than their parental counterpart (Table [4](#T4){ref-type="table"}). Similarly, there was threefold increase in binding to HTB-9 cells for CFT073 Δ*dam* mutants. We also noted favorable attachment of wild-type and Δ*dam* strains to HTB-9 cells (relative to HEK-293) ranging from 16- to 6-fold (for cC119) to 9- to 7-fold (for CFT073), respectively.

###### 

**Data representing mean ± SD of separate experiments for attachment assay of CFT073 wt, CFT073 Δ*dam* mutant, cC119, and cC119 Δ*dam* mutant to HEK-293 kidney and HTB-9 bladder cells**.

  *E. coli* strain   Colony count                                                    
  ------------------ -------------- ------------- ----- ------------- -------------- -----
  CFT073 wt          1.55 ± 0.35    3.02 ± 2.51   5.1   3.02 ± 2.51   11.6 ± 6.58    2.6
  CFT073 Δ*dam*      0.55 ± 0.05    3.04 ± 2.91   1.8   3.04 ± 2.91   3.97 ± 0.73    7.7
  cC119              5.20 ± 0.10    11.9 ± 7.73   4.4   11.9 ± 7.73   52.2 ± 18.27   2.3
  cC119 Δ*dam*       1.70 ± 0       4.10 ± 2.95   4.1   4.10 ± 2.95   15.3 ± 10.01   2.7

Discussion {#S4}
==========

The molecular basis of epidemiological studies serves as the most substantial tool in understanding the pathogenesis and transmission of pathogens. In this study, the *dam* was identified as the prime source of DNA methylation in UPEC subsequent to *dam* gene interruption. Successful disruption by allelic exchange results in the partial substitution of archetypical alleles with inserts on the bacterial chromosome. Moreover, attempts at *dam* complementation proved successful in restoration of *dam* function (suppression of elongated cells and cell division defect), growth rate, biofilm formation, and gene expression studies. The pleomorphic appearance of filamentous, elongated rods among Δ*dam* strains when compared to those of wild type origin (shortened rods) denoted phenotypic similarity among the Enterobacteriales as reported by previous studies of *E. coli* K12 ([@B29]) and EHEC OH157:O7 ([@B26]). This modification points to the impact of *dam* methylation on several cellular processes in related bacteria in the orders Enterobacteriales since Dam is essential to DNA replication, gene expression regulation and mismatch repair induced by the SOS regulon ([@B69]).

The SOS regulon constitutes a collective series of over 30 genes executing a myriad of biological effects following interference in cell division, DNA replication, or damage ([@B70], [@B71]). These genes (*rec*A, *lex*A, *sul*A, *pol*B, *uvr*AB, *din*DF, etc.) dispersed around the chromosome are negatively regulated and repressed ([@B72]). Cell rescue subsequent to stress exposure by exogenous DNA damaging agents (e.g., UV irradiation, nalidixic acid, superoxides, 2-aminopurine) chiefly involves the interplay of RecA and LexA proteins required in expression of the regulon ([@B72], [@B73]). The single-stranded DNA assemblage of coprotease RecA mediates self-cleavage of LexA, the transcriptional repressor protein to activate the transcription of SOS response genes ([@B74]). Studies on the interplay of Dam with SOS regulation confirm its role as part of the recombinational repair system since deficiency results in pleiotropic changes as seen in Δ*dam* cells ([@B75], [@B76]). Hence, the filamentous appearance of mutant cells are assumed to be an indirect outcome of *dam* deficiency, of which the SulA protein activated in the latter part of SOS induction inhibited cell division and extended the period for DNA repair ([@B74]). More specifically, the inhibition of FtsZ polymerization by SulA prevents septation of cells and mutant DNA transfer to daughter cells since the absence of hemimethylated DNA at the replication fork profoundly alters initiation of chromosome replication. Post-DNA repair, SOS regulation is repressed by LexA and SulA is degraded to restore normal cell division ([@B71], [@B77]). Filamentation in response to SOS induction by DNA damaging elements of exogenous or innate immune response (polymorphonuclear leukocytes) origins may therefore serve as a means of pathogenicity as seen in the latter stage UPEC biofilm formation than singly a mechanism of survival ([@B71]).

In regards to growth rate of *dam* mutants, the prolonged lag phase preceding the comparable logarithmic phase trend to that of parental strains was noted and has also been described in *dam* mutants of *Acinetobacter actinomycetemcomitans* ([@B78]). The reduction in cell count among mutants points to the role of Dam methylase in initiating and coordinating chromosome DNA replication, nucleoid segregation, gene expression, and ultimately cell division. In *E. coli*, the replication of *dna*A-dependent chromosome from the origin of replication (*ori*C) is minimal to lacking in the absence of complete methylation of *ori*C GATC sites by Dam ([@B79], [@B80]). Hemimethylated origin will remain inactive, and further prevent methylation of daughter DNA strands during DNA replication since the origin is sequestered by SeqA. SeqA sequestering represses the initiation of new DNA replication cycles, *dam* regulation of the initiator DnaA promoter synthesis similarly to OriC and eventually the cell cycle, as reinitiation of chromosome replication within the same cell cycle ensues. Subsequently, DNA replication initiation is uncoordinated ([@B81], [@B82]) with defects in nucleoid structure due to the inability to form compacted chromosome structure for the organization of nascent nucleoids and decatenation of topoisomerase IV ([@B79], [@B82]). Comparatively, the observation of typical logarithmic growth among Δ*dam* mutants to that of the wild type, confirms non-essential role of *dam* expression for viability of UPEC. However, *dam* does trigger hypervariability mechanisms, which may also impact the activation of physiological pathways required for growth under specific conditions. This is in agreement with observations made for Δ*dam* mutants of *E. coli* and *Salmonella* ([@B30]).

The extended lag phase among *dam* mutants *in vitro* may occur during acclimatization of Δ*dam* strains to the growth environment and is speculated to be a direct result of the absence of Dam's correlative activity in initiating synchronized chromosomal replication at *ori*C and the replication fork during cell growth ([@B83]). Additionally, among *dam* plasmid-bearing wild types, prolonged lag phases may be accountable to multicopied *dam* complement plasmid strains serving as *seq*A phenocopies despite Dam overproduction resulting in the subsequent inhibition of SeqA ([@B84]). Rasmussen et al. ([@B85]) have linked the level of Dam methylase production to growth rate. Hence, the observed delay in logarithmic growth may be accountable to the lack of GATC methylation for post-replicative mismatch repair of newly replicated DNA ([@B80]) alongside SulA activation during the SOS response ([@B74]).

In the absence of Dam methylation, post-replicative errors or chronic DNA damage may trigger homologous recombination, an event heavily relied upon by Δ*dam* strains for repair subsequent to lesions, nicks or double-stranded breaks in DNA ([@B29], [@B76], [@B80]). As reported among *Salmonella* exposed to stress induced environments, such contributory factors result in increased mutability with the upregulation of the SOS regulon ([@B86], [@B87]). Equally, *dam* mutant UPEC strains may display increased spontaneous mutation frequency and hyperrecombinogenicity ([@B76]), the latter required to repair replication forks subsequent to numerous nicks in the single strand of DNA of the growing bacterial cell ([@B88]). The hypersensitivity and hypermutability demonstrated by *dam* mutants to agents (2-amino purine, ultraviolet light and reactive oxygen species) causing DNA mismatch, lesions or mutations have also been associated with the endonuclease activity of the MutHLS complex ([@B79]). Reports by Chen et al. ([@B61]) and Zaleski and Piekarowicz ([@B89]) similarly indicated the increased hypersensitive nature of *dam*-deficient strains to DNA-damaging agents or reactive oxygen species. Furthermore, research has shown that the Agn43 outer membrane protein involved in biofilm formation in *E. coli* is epigenetically regulated by competitive binding between OxyR (global oxidative stress protein) and Dam. Absence of methylation within GATC sites of the antigen 43 (*agn*43) gene promoter region has been reported to lead to lowered growth rates and may have influenced outcomes of biofilm formation assays for this study ([@B90], [@B91]).

Biofilm formation contributes to the *in vivo* survival and persistence of UPEC during UTI and plays a pivotal role in the colonization of the urogenital tract ([@B92]). The production of oxidative radicals by uroepithelial cells have been reported to enhance UPEC fitness by the induction of DNA repair systems to combat proceeding exposures, subsequent to infection -- a characteristic critical for virulence ([@B93]). Interestingly, after 24 h of exposure *dam* mutants strains displayed greater persistence rates (higher cell density) but variable responses to increases in reactive oxygen species. This may be attributed to spontaneous mutation frequencies among such strains since the oxidative stress response proteins OxyR and SoxRS (principal regulators for hydrogen peroxide detoxification) in *E. coli* are competitive to Dam for overlapping GATC sites in, or near promoters ([@B94]). Additionally, the negative regulation of the antigen 43 phase variable biofilm formation autotransporter boosts autoaggregation and 3D appearance ([@B94]). In the absence of *dam*, the phase variation protein binding (epigenetic switch) at three GATC sites in *agn*43 (*flu*) is hampered since activation occurs subsequent to methylation ([@B34]). Contrary to expected outcomes, this should lower cell aggregation among mutant cells. However, the augmented occurrence of stress-induced mutagenesis and repair activated by upregulated SOS gene expression may account for elevated levels of biofilm formation among UPEC *dam* mutants, contrary to at least one report of increased sensitivity among *E. coli dam* mutants by Calmann and Marinus ([@B95]).

Further antimicrobial susceptibility studies conducted on cured and pGEMQA C119 parental and *dam-*mutant strains as well as pGEMQA transformants of CFT073 wild type and *dam-*mutant strains indicated variable phenotypic responses. Likewise, the capricious observation for *dam-*mutant strains (further enhanced with the presence of pGEMQA by up to threefold that of parental and *dam* complement strains) may have been a result of SOS activation triggered by quinolones inhibiting the topoisomerase IV activity ([@B72], [@B82]). Dam-mutant strains of C119 were notably altered in resistance against various classes of antimicrobial agents by as much as eightfold in comparison to parental strains. Such variability displayed among mutants could be attributed to increased mutation rates and accumulating secondary mutations during growth. The latter would be of significant survival value in the presence of increased SOS response activators (oxidative and DNA damaging stress) and for the purpose of increased biofilm structure production.

The contribution of Dam methylation to the expression and adherence of virulence factor type 1 fimbriae in UPEC to host cells is well known to have a perceptible effect ([@B38]). Equally, Dam's role in the epigenetic switch of P fimbriae is of significance to the pathogenicity of uropathogenic *E. coli* strains implicated in UTIs. Transcriptionally controlled by cooperative binding of the leucine-responsive regulatory protein (Lrp) and translocation by ancillary protein PapI, the Pap phase variation is dependent on Dam methylation along the GATC sites upstream the *pap*BA-regulatory region ([@B80]). However, it was not until Campellone et al. ([@B26]) reported on the increased adherence of EHEC *dam* mutants to cultured mammalian cells when compared to wild-type EHEC that it was clear the absence of Dam function somehow triggered alternate virulence pathways; in this case, negatively regulating binding to host cells. Similarly, we make the first report of this phenomenon by UPEC Δ*dam* strains compared to wild-type strains with the preferred adherence of mutant strains to cultured HTB-9 bladder cells. While it is clear that there are differences in attachment between *dam* mutant and wild-type strains, it does not preclude the involvement of other uroadhesion mechanisms which share regulatory features to *pap*, e.g., afimbrial adhesin, and Type 1 and S fimbriae ([@B96]). Moreover, comparable to previous findings ([@B25]), the subtle adherence exhibited by UPEC strains to cell culture models (post-1.5 h) coincides with discrepancies noted since up to 40% of UPEC isolates display no adherence to uroepithelial cells, are almost always afimbriated and thus, may not adhere when freshly isolated or cultured ([@B7]).

Furthermore, semi-quantitative RT-PCR results also reflected this variation in gene expression as there was a measurable increase in the transcription levels of the *pap*I gene of Δ*dam* versus wild-type bacteria, suggesting that the increase in fimbriae is a direct result of alteration to the transcription initiation at regulatory sites. In this case, the alteration may have been the lack of *dam* methylation pattern control at both distal and proximal sites within the *pap* regulatory DNA leading to a constant phase ON switch for expression of the operon; a finding consistent with the report by Marinus and Casedesús ([@B34]). It is hypothesized that the reversible expression of *pap* allows the bacteria to attach and detach from the urogenital tissues as needed. In theory this enables colonization and infection of the bladder, then subsequently the kidney, leading to cystitis and pyelonephritis, respectively ([@B33]). However, the preferential attachment of the UPEC strains to bladder cells (seen in this study) may indicate either the occurrence of variation in PapG adhesin specificity to globoseries of the tubular mucosal cells, or the associated level of pathogenicity potential for causing infection in these tissues ([@B17], [@B20], [@B21]).

Notably, the increased expression of *rec*A, *pap*I, and *qnr*A but decreased or absent expression of *dam, mdh, pap*EF, *arc*A, *gyr*B observed among *dam* mutant and *dam*-complement strains comparative to wild-types, underscores the high level of altered phenotypes present as a result of altered gene expression. Numerous studies with RecA have indicated its role as chief regulator in SOS induction, homologous recombination mechanisms and eventual phenotypic variations by means of phenotypic switching ([@B72], [@B74], [@B88]). In the presence of environmental changes (e.g., oxidative stress, DNA damage), the interplay between *dam* and *rec*A may be integral to the altered responses of cells for adaptation. Evidence points to increased minimal level of expression of *rec*A in *dam* mutants relative to wild-type strains ([@B88], [@B97]). Various studies have shown the full functional capability of methyl-directed mismatch repair in *E. coli dam* mutants to induce increased nucleotide base substitutions and mutagenic double-stranded breaks ([@B72], [@B88]). Such occurrences contribute to the increased mutability and hypervariation demonstrated by mutant strains ([@B87], [@B98]). Moreover, excessive recombinational events and insufficient repair of chromosome breaks in *dam* mutants eventually leads to cell death as shown by the non-viability of double mutants of *dam rec*A, *dam ruv*A, *dam pol*A, *dam lig*, and *dam pri*A ([@B76], [@B88]).

The preferential expression and modulation of several virulence genes by *dam* mutants (relative to wild-type) of pathogenic *Salmonella* strains ([@B36]) advocates the therapeutic potential of attenuated strains as live vaccines ([@B33], [@B36], [@B47]) and Dam inhibitors as antibacterial drugs ([@B38], [@B46]). Despite this background, our findings illustrating sustained viability and low level of adherence *in vitro* to uroepithelial cells by Δ*dam* UPEC strains may dampen the prospect for solitary use of Dam inhibitors or UPEC Δ*dam* strains as live vaccines. Further characterization and post-transcriptional and *in vivo* investigations for the influence of DNA adenine methylation on virulence gene regulation may reveal associated regulatory networks and their value to vital functions indispensable to pathogenicity of UPEC and other bacteria.
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